Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<i>Talaromyces marneffei</i> causes fatal invasive mycosis in Southeast Asia. Diagnosis by culture has limited sensitivity and can result in treatment delay. We describe the use of a novel Mp1p enzyme immunoassay (EIA) to identify blood culture-negative talaromycosis, subsequently confirmed by bone marrow cultures. This EIA has the potential to speed diagnosis, enabling early therapy initiation.

Original publication

DOI

10.1093/ofid/ofaa502

Type

Journal

Open forum infectious diseases

Publication Date

11/2020

Volume

7

Addresses

University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.